Cargando…
Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice
In a transgenic mouse line hK14mIL33tg, with the expression of interleukin-33 (IL-33) driven by a keratin 14 promoter, keratoconjunctivitis developed spontaneously between 18 and 22 weeks of age under specific-pathogen-free conditions. These mice showed blepharitis and corneal impairments, and the h...
Autores principales: | Imai, Yasutomo, Hosotani, Yuka, Ishikawa, Hiroto, Yasuda, Koubun, Nagai, Makoto, Jitsukawa, Orie, Gomi, Fumi, Nakanishi, Kenji, Yoshimoto, Tomohiro, Nakamura, Takahiro, Yamanishi, Kiyofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577277/ https://www.ncbi.nlm.nih.gov/pubmed/28855579 http://dx.doi.org/10.1038/s41598-017-10227-y |
Ejemplares similares
-
40 Contribution of IL-33 and Nuocyte to Experimental Allergic Dermatitis
por: Imai, Yasutomo, et al.
Publicado: (2012) -
Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis
por: Imai, Yasutomo, et al.
Publicado: (2021) -
Activation of Molecular Signatures for Antimicrobial and Innate Defense Responses in Skin with Transglutaminase 1 Deficiency
por: Haneda, Takashi, et al.
Publicado: (2016) -
Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2
por: Nakatani-Kusakabe, Minori, et al.
Publicado: (2021) -
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022)